Core Insights - West Point Pharmaceuticals (301130.SZ) released its Q3 2025 report on October 28, 2025, indicating a total of 8 institutional investors holding shares, amounting to 18.83 million shares, which represents 24.62% of the total share capital [1] Institutional Holdings - The institutional investors include Dingdian Investment Management (Beijing) Co., Ltd., Zhuhai Hengqin Yanhe Health Technology Co., Ltd., and several others, with a total institutional holding percentage of 24.62% [1] - Compared to the previous quarter, the total institutional holding percentage decreased by 0.30 percentage points [1] Public Fund Holdings - One new public fund, Yimin Core Growth Mixed Fund, was disclosed this quarter, while 23 public funds were not disclosed compared to the previous quarter [1] - Notable funds that were not disclosed include Nuon An Multi-Strategy Mixed A, Everbright Baode Trust Quantitative Stock A, and others [1]
机构风向标 | 西点药业(301130)2025年三季度已披露持仓机构仅8家